Reposted with permission from the American Institute for Medical and Biological Engineering
WASHINGTON, D.C. — The American Institute for Medical and Biological Engineering (AIMBE) has
announced the induction of Douglas J. Weber, Ph.D., Associate Professor, Bioengineering, University of
Pittsburgh to its College of Fellows.
Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a
medical and biological engineer. The College of Fellows is comprised of the top two percent of medical
and biological engineers. College membership honors those who have made outstanding contributions
to "engineering and medicine research, practice, or education” and to "the pioneering of new and
developing fields of technology, making major advancements in traditional fields of medical and
biological engineering, or developing/implementing innovative approaches to bioengineering
Dr. Weber was nominated, reviewed, and elected by peers and members of the College of Fellows for
“outstanding contributions to neurorehabilitation engineering, translational neuroscience, and
leadership in the field of neural engineering.”
As a result of health concerns, AIMBE’s annual meeting and induction ceremony scheduled for March
29-30, 2020, was cancelled. Under special procedures, Dr. Weber was remotely inducted along with
156 colleagues who make up the AIMBE College of Fellows Class of 2020.
While most AIMBE Fellows hail from the United States, the College of Fellows has inducted Fellows
representing 34 countries. AIMBE Fellows are employed in academia, industry, clinical practice and
AIMBE Fellows are among the most distinguished medical and biological engineers including 3 Nobel
Prize laureates, 18 Fellows having received the Presidential Medal of Science and/or Technology and
Innovation, and 173 also inducted to the National Academy of Engineering, 84 inducted to the National
Academy of Medicine and 37 inducted to the National Academy of Sciences.
# # #
AIMBE is the authoritative voice and advocate for the value of medical and biological engineering to
society. AIMBE’s mission is to recognize excellence, advance the public understanding, and
accelerate medical and biological innovation. No other organization can bring together academic,
industry, government, and scientific societies to form a highly influential community advancing
medical and biological engineering. AIMBE’s mission drives advocacy initiatives into action on
Capitol Hill and beyond.
Contact: Charlie Kim